EMA Issues Negative Opinion on AMX003 to Treat Adults with Amyotrophic Lateral Sclerosis (ALS)
source: pixabay.com

EMA Issues Negative Opinion on AMX003 to Treat Adults with Amyotrophic Lateral Sclerosis (ALS)

The long-awaited decision by the European committee CHMP was announced recently by Amylyx Pharmaceutical (the Company) based in Cambridge, Massachusetts just as anticipated. The EMA issued its negative opinion of…

Continue Reading EMA Issues Negative Opinion on AMX003 to Treat Adults with Amyotrophic Lateral Sclerosis (ALS)
Why Me, Why Not
source: Lauren Williams

Why Me, Why Not

NOTE: This story was provided through the CureGRIN Foundation, a Patient Worthy partner organization.  Written by Lauren Williams Why Me, Why Not A question I struggled terribly with at the…

Continue Reading Why Me, Why Not
Researchers Use AI to Identify New Cystinosis Treatment Targets
source: shutterstock.com

Researchers Use AI to Identify New Cystinosis Treatment Targets

According to a story from SciTech Daily, a team of researchers affiliated with the University of Zurich's ITINERARE University Research Priority Program recently collaborated with Insilico Medicine to conduct research…

Continue Reading Researchers Use AI to Identify New Cystinosis Treatment Targets
He Battled Acute Flaccid Myelitis (AFM)—And Now He’s Back to Playing Baseball!
Source: pixabay.com

He Battled Acute Flaccid Myelitis (AFM)—And Now He’s Back to Playing Baseball!

Two days. That’s all it took for Jill and Jeff Ackermann to watch their son’s condition mysteriously deteriorate. On Saturday, six-year-old Bryson was the energetic, athletic, and bright-eyed little boy…

Continue Reading He Battled Acute Flaccid Myelitis (AFM)—And Now He’s Back to Playing Baseball!
Phase 3 Trial Evaluating Magrolimab Combo for MDS Discontinued for Futility
source: shutterstock.com

Phase 3 Trial Evaluating Magrolimab Combo for MDS Discontinued for Futility

In 2020, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation to magrolimab for the treatment of newly diagnosed myelodysplastic syndromes (MDS). This designation is designed to expedite…

Continue Reading Phase 3 Trial Evaluating Magrolimab Combo for MDS Discontinued for Futility
A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval
source: shutterstock.com

A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval

According to a story from Market Screener, the drug company AbbVie recently announced that its investigational therapy epcoritamab has received a positive opinion from the European Union's Committee for Medicinal…

Continue Reading A New Treatment for Diffuse Large B-Cell Lymphoma Could be on its Way to EU Approval
Rare Community Profiles: AlphaID At Home Provides Accessible, Targeted Screening for Alpha-1 Antitrypsin Deficiency (AATD)
Source: https://pixabay.com/en/upper-body-lung-copd-disease-944557/

Rare Community Profiles: AlphaID At Home Provides Accessible, Targeted Screening for Alpha-1 Antitrypsin Deficiency (AATD)

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: AlphaID At Home Provides Accessible, Targeted Screening for Alpha-1 Antitrypsin Deficiency (AATD)
Development of a Personalized Treatment for a Single Patient Could Pave the Future for Custom Therapies
luvqs / Pixabay

Development of a Personalized Treatment for a Single Patient Could Pave the Future for Custom Therapies

  Professor Timothy Yu developed the custom drug milasen named in honor of Mila, an 8-year-old girl with Batten disease. The drug is the first drug specifically designed for one…

Continue Reading Development of a Personalized Treatment for a Single Patient Could Pave the Future for Custom Therapies
Granulomatosis with Polyangiitis: Removal of Wisdom Teeth Eventually Led to a Lung Transplant for this Teen
source: pixabay.com

Granulomatosis with Polyangiitis: Removal of Wisdom Teeth Eventually Led to a Lung Transplant for this Teen

Lonnie's mother, Stephanie Pesterfield of Colorado Springs, still finds it difficult to talk about her son Lonnie’s near-death experience. Yet as published recently in People, Stephanie and her son want…

Continue Reading Granulomatosis with Polyangiitis: Removal of Wisdom Teeth Eventually Led to a Lung Transplant for this Teen
“One in a Million Diagnosis:” Family Raises Awareness after 16-Month-Old is Diagnosed with JMML
source: shutterstock.com

“One in a Million Diagnosis:” Family Raises Awareness after 16-Month-Old is Diagnosed with JMML

Marco and India Biviano felt like something bad was happening to their young son Luca. His stomach was distended and painful. Luca frequently developed chest infections that required round after…

Continue Reading “One in a Million Diagnosis:” Family Raises Awareness after 16-Month-Old is Diagnosed with JMML
Scientists May Have Found a Possible Cure for Acute Leukemia in Base Edited T-Cells
https://pixabay.com/en/children-road-distant-supportive-1149671/

Scientists May Have Found a Possible Cure for Acute Leukemia in Base Edited T-Cells

Leukemia is cancer that begins in the bone marrow and involves abnormal white blood cells (WCB) from lymphatic tissues and bone marrow. Scientists have new theories as to why certain…

Continue Reading Scientists May Have Found a Possible Cure for Acute Leukemia in Base Edited T-Cells